Easterly Investment Partners LLC Co Diagnostics, Inc. Transaction History

Easterly Investment Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Nov 13, 2023	BUY	$2.32 - $3.68 $288,123 - $457,022	124,191 New	124,191 $312,000
Q4 2022 Feb 10, 2023	SELL	$2.32 - $3.68 $17,084 - $27,099	-7,364 Reduced 5.7%	121,826 $307,000
Q2 2022 Aug 10, 2022	SELL	$3.76 - $6.29 $48,880 - $81,770	-13,000 Reduced 9.14%	129,190 $725,000
Q1 2022 May 13, 2022	SELL	$5.03 - $9.61 $75,450 - $144,150	-15,000 Reduced 9.54%	142,190 $879,000
Q4 2021 Aug 02, 2022	BUY	$8.12 - $10.37 $19,203 - $24,525	2,365 Added 1.53%	157,190 $1.4 Million
Q4 2021 Feb 08, 2022	SELL	$8.12 - $10.37 $59,803 - $76,375	-7,365 Reduced 4.54%	154,825 $1.38 Million
Q3 2021 Nov 16, 2021	BUY	$7.48 - $11.38 $1.21 Million - $1.85 Million	162,190 New	162,190 $1.58 Million

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $27.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Easterly Investment Partners LLC with notifications on news.